throbber
IPR2024-00009
`U.S. Patent 10,335,462
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`DR. REDDY’S LABORATORIES, INC. AND DR. REDDY’S
`LABRATORIES LTD,
`Petitioners
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2024-00009
`Patent 10,335,462
`______________________
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`
`
`

`

`IPR2024-00009
`U.S. Patent 10,335,462
`Pursuant to 37 C.F.R. § 42.8, Patent Owner, Novo Nordisk A/S, hereby
`
`submits Mandatory Notice.
`
`I.
`
`REAL PARTIES-IN-INTEREST (37 C.F.R. § 42.8(b)(1))
`The real party-in-interest is Patent Owner Novo Nordisk A/S. Out of an
`
`abundance of caution, Patent Owner also identifies, as a potential real party-in-
`
`interest, exclusive licensee Novo Nordisk Inc. for purposes of providing notice.
`
`The listing of a potential real party-in-interest entity should not be deemed as an
`
`acknowledgement that, inter alia, any such entity actually controls this matter.
`
`II.
`
`RELATED MATTERS (37 C.F.R. § 42.8(b)(2))
` Novo Nordisk A/S identifies the following judicial and administrative
`
`matters that concern or concerned U.S. Patent No. 10,335,462.
`
`• Mylan Pharmaceuticals Inv. v. Novo Nordisk A/S, IPR2023-00724
`
`(P.T.A.B.)
`
`• Novo Nordisk Inc., et al. v. Mylan Pharmaceuticals Inc., C.A. 22-23
`
`(IMK) (N.D. W. Va.) transferred to D. Del. as 22-1040 (CFC)
`
`• Novo Nordisk Inc. et al. v. Mylan Pharmaceuticals Inc., C.A. 22-1040
`
`(CFC) (D. Del.)
`
`• In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 22-MD-
`
`3038 (CFC) (D. Del.)
`
`1
`
`

`

`IPR2024-00009
`U.S. Patent 10,335,462
`• Novo Nordisk Inc. et al. v. Rio Biopharmaceuticals, Inc. et al., C.A.
`
`22-294 (CFC) (D. Del.)
`
`• Novo Nordisk Inc. et al. v. Aurobindo Pharma USA, Inc. et al., C.A.
`
`22-295 (CFC) (D. Del.)
`
`• Novo Nordisk Inc. et al. v. Sun Pharmaceuticals Industries Ltd. et al.,
`
`C.A. 22-296 (CFC) (D. Del.)
`
`• Novo Nordisk Inc. et al. v. Zydus Worldwide DMCC et al., C.A. 22-
`
`297 (CFC) (D. Del.)
`
`• Novo Nordisk Inc. et al. v. Dr. Reddy’s Laboratories Ltd. et al., C.A.
`
`22-298 (CFC) (D. Del.)
`
`• Novo Nordisk Inc. et al. v. Alvogen, Inc., C.A. 22-299 (CFC) (D. Del.)
`
`III. LEAD AND BACK-UP COUNSEL AND SERVICE
`INFORMATION UNDER §§42.8(b)(3)-(4):
`Lead:
`J. Steven Baughman (Reg. No. 47,414)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5832
`steve.baughman@groombridgewu.com
`
`
`Backup: Megan Raymond (Reg. No. 72,997)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5878
`megan.raymond@groombridgewu.com
`
`2
`
`

`

`IPR2024-00009
`U.S. Patent 10,335,462
`
`
`
`
`Novo Nordisk A/S consents to service through the counsel identified above.
`
`Electronic service of documents must be sent to each of the listed email
`
`addresses of the counsel and Novo-Semaglutide-IPR@groombridgewu.com. To
`
`the extent physical documents are served on Novo Nordisk A/S. please address any
`
`such correspondence to lead counsel and back-up counsel at the following mailing
`
`address: J. Steven Baughman, Megan Raymond, GROOMBRIDGE, WU,
`
`BAUGHMAN & STONE LLP, 801 17th Street, NW, Suite 1050, Washington,
`
`DC, 20006.
`
`
`Respectfully submitted,
`
`Dated: November 1, 2023
`
`
`
`By: /Megan Raymond/
`
`J. Steven Baughman (Reg. No. 47,414)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5832
`steve.baughman@groombridgewu.com
`
`Megan Raymond (Reg. No. 72,997)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5878
`megan.raymond@groombridgewu.com
`
`
`Attorneys for Patent Owner Novo Nordisk A/S
`
`3
`
`
`
`

`

`CERTIFICATE OF SERVICE
`
`IPR2024-00009
`U.S. Patent 10,335,462
`
`The undersigned hereby certifies that a copy of PATENT OWNER’S
`
`MANDATORY NOTICE UNDER 37 C.F.R. § 42.8 has been served in its entirety
`
`on November 1, 2023, by causing the aforementioned document to be
`
`electronically mailed to the following attorneys of record for the Petitioner listed
`
`below.
`
`Petitioner’s Counsel of Record:
`
`Lead Counsel:
`
`Jovial Wong
`Reg. No. 60,115
`Winston & Strawn LLP
`1901 L Street NW
`Washington, DC 20036
`Telephone: (202) 282-5867
`jwong@winston.com
`
`By Electronic Mail
`Backup Counsel: Scott Border
`Reg. No. 77,744
`Winston & Strawn LLP
`1901 L Street NW
`Washington, DC 20036
`Telephone: (202) 285-5054
`sborder@winston.com
`
`Sharon Lin McIntosh
`(pro hac vice to be submitted)
`Winston & Strawn LLP
`1901 L Street NW
`Washington, DC 20036
`Telephone: (202) 285-5756
`slin@winston.com
`
`By Electronic Mail
`
`4
`
`

`

`Dated: November 1, 2023
`
`
`
`
`
`IPR2024-00009
`U.S. Patent 10,335,462
` Respectfully submitted,
`By: /Sayem Osman
`Sayem Osman
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket